Cargando…
COVID-19 Pediatric Vaccine Hesitancy among Racially Diverse Parents in the United States
On 29 October 2021, the U.S. FDA authorized the Pfizer-BioNTech COVID-19 (SARS-CoV-2) vaccine for emergency use in children ages 5–11 years. Racial/ethnic minorities have born the greatest burden of pediatric COVID-19 infection and hospitalization. Research indicates high prevalence of parental vacc...
Autores principales: | Fisher, Celia B., Gray, Aaliyah, Sheck, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778198/ https://www.ncbi.nlm.nih.gov/pubmed/35062692 http://dx.doi.org/10.3390/vaccines10010031 |
Ejemplares similares
-
Determinants of COVID-19 Vaccine Uptake in Adolescents 12–17 Years Old: Examining Pediatric Vaccine Hesitancy Among Racially Diverse Parents in the United States
por: Gray, Aaliyah, et al.
Publicado: (2022) -
COVID-19 Vaccine Hesitancy among Parents of Children under Five Years in the United States
por: Fisher, Celia B., et al.
Publicado: (2022) -
Factors associated with HPV vaccine acceptability and hesitancy among Black mothers with young daughters in the United States
por: Gray, Aaliyah, et al.
Publicado: (2023) -
COVID-19 Vaccine Hesitancy among Economically Marginalized Hispanic Parents of Children under Five Years in the United States
por: Fisher, Celia, et al.
Publicado: (2023) -
COVID-19 vaccine hesitancy among low-income, racially and ethnically diverse US parents
por: Schilling, Samantha, et al.
Publicado: (2022)